Peptable

Comparison

Selank vs Setmelanotide

Function

While Selank is a peptide developed in Russia as an anxiolytic and nootropic; in animal models it reduces anxiety-like behavior and modulates immune parameters under stress39, Setmelanotide is approved for chronic weight management in patients with POMC, PCSK1, LEPR deficiencies and Bardet–Biedl syndrome by reducing hunger and promoting weight loss92.

Mechanism

While Selank works as a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, that combines a tuftsin fragment with a Pro-Gly-Pro motif and is reported to modulate GABAergic neurotransmission and cytokine balance while being resistant to proteolytic degradation39, Setmelanotide is a potent synthetic melanocortin-4 receptor (MC4R) agonist derived from a POMC/α-MSH–related sequence that restores downstream MC4R signaling in genetic obesity syndromes3192100.

Receptor

Selank

Not clearly established in the current dataset.

Setmelanotide

Melanocortin-4 receptor (MC4R) 3192100

Organism or Origin

Selank

Synthetic analog of the IgG-derived tetrapeptide tuftsin39

Setmelanotide

Synthetic analog of POMC-derived α-MSH peptide928190

Gene

Selank

Not assigned in the current dataset.

Setmelanotide

POMC

Summary

Both peptides fall into a similar broad context as Neuropeptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Selank is more often discussed in the realm of Neurology and brain health and Immunology and inflammation, whereas Setmelanotide is more often associated with the realm of Metabolic and endocrine. They also influence different molecular systems, with Selank tracking more closely to GPCR receptor while Setmelanotide centers more on Melanocortin receptor. Selank has a more synthetic analog origin, while Setmelanotide is closer to synthetic design background and their development context also differs, with Selank approved for Research use only while Setmelanotide is approved. Selank takes the form of a linear peptide, whereas Setmelanotide is closer to a cyclic peptide, Setmelanotide incorporates d-amino acid substitution features that are not part of Selank; while their sequence patterns also diverge, with Selank showing proline-rich features and Setmelanotide showing protein-mimetic sequence features.

Related articles

No related articles are linked to these peptides yet.

Sources

39Application of thr-lys-pro-arg-pro-gly-pro peptide (selank) for ..., https://patents.google.com/patent/RU2629832C1/en
31[PDF] 213793Orig1s000 - accessdata.fda.gov, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213793Orig1s000PharmR.pdf
81Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC2253185/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/
92Setmelanotide, https://go.drugbank.com/drugs/DB11700
100Multiple Independent Sub-studies of Setmelanotide in, https://onderzoekmetmensen.nl/en/node/53452/pdf